JP2006514645A5 - - Google Patents

Download PDF

Info

Publication number
JP2006514645A5
JP2006514645A5 JP2004560488A JP2004560488A JP2006514645A5 JP 2006514645 A5 JP2006514645 A5 JP 2006514645A5 JP 2004560488 A JP2004560488 A JP 2004560488A JP 2004560488 A JP2004560488 A JP 2004560488A JP 2006514645 A5 JP2006514645 A5 JP 2006514645A5
Authority
JP
Japan
Prior art keywords
hydroxy tamoxifen
subject
transdermally
performing mammography
transdermally administering
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004560488A
Other languages
English (en)
Japanese (ja)
Other versions
JP4684655B2 (ja
JP2006514645A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2003/015030 external-priority patent/WO2004054558A2/en
Publication of JP2006514645A publication Critical patent/JP2006514645A/ja
Publication of JP2006514645A5 publication Critical patent/JP2006514645A5/ja
Application granted granted Critical
Publication of JP4684655B2 publication Critical patent/JP4684655B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2004560488A 2002-12-18 2003-12-15 4−ヒドロキシタモキシフェンによる乳房密度低下 Expired - Lifetime JP4684655B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43395802P 2002-12-18 2002-12-18
PCT/EP2003/015030 WO2004054558A2 (en) 2002-12-18 2003-12-15 Reduction of breast density with 4-hydroxy tamoxifen

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010279107A Division JP2011052020A (ja) 2002-12-18 2010-12-15 4−ヒドロキシタモキシフェンによる乳房密度低下

Publications (3)

Publication Number Publication Date
JP2006514645A JP2006514645A (ja) 2006-05-11
JP2006514645A5 true JP2006514645A5 (https=) 2007-02-08
JP4684655B2 JP4684655B2 (ja) 2011-05-18

Family

ID=32595254

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2004560488A Expired - Lifetime JP4684655B2 (ja) 2002-12-18 2003-12-15 4−ヒドロキシタモキシフェンによる乳房密度低下
JP2010279107A Pending JP2011052020A (ja) 2002-12-18 2010-12-15 4−ヒドロキシタモキシフェンによる乳房密度低下

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010279107A Pending JP2011052020A (ja) 2002-12-18 2010-12-15 4−ヒドロキシタモキシフェンによる乳房密度低下

Country Status (6)

Country Link
US (1) US7485623B2 (https=)
EP (3) EP1952809B1 (https=)
JP (2) JP4684655B2 (https=)
AU (1) AU2003296757A1 (https=)
DE (1) DE60327363D1 (https=)
WO (1) WO2004054558A2 (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005513080A (ja) * 2001-12-20 2005-05-12 フェムファーマ, インコーポレイテッド 薬物の膣送達
MXPA05006526A (es) * 2002-12-18 2006-02-17 Besins Int Lab Tratamiento de mastalgia con 4-hidroxi tamoxifen.
US9173836B2 (en) 2003-01-02 2015-11-03 FemmeParma Holding Company, Inc. Pharmaceutical preparations for treatments of diseases and disorders of the breast
MXPA05007266A (es) * 2003-01-02 2006-01-17 Femmepharma Holding Co Inc Preparaciones farmaceuticas para tratamientos de enfermedades y trastornos del seno.
ES2456958T3 (es) * 2003-04-01 2014-04-24 Besins Healthcare Luxembourg Sarl Formulaciones para prevención y tratamiento de cáncer de seno con 4-hidroxi tamoxifen
JP4682129B2 (ja) 2003-06-09 2011-05-11 アセンド セラピュティクス インコーポレイテッド 4−ヒドロキシタモキシフェンによる過剰瘢痕化の治療及び予防
US7968532B2 (en) * 2003-12-15 2011-06-28 Besins Healthcare Luxembourg Treatment of gynecomastia with 4-hydroxy tamoxifen
EP1579856A1 (en) * 2004-03-22 2005-09-28 Laboratoires Besins International Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen
PT1748770E (pt) * 2004-03-22 2008-07-16 Besins Int Lab Tratamento e prevenção de doença benigna da mama com 4-hidroxi-tamoxifeno
US20050208139A1 (en) * 2004-03-22 2005-09-22 Ascend Therapeutics, Inc. Chemically stable compositions of 4-hydroxy tamoxifen
US7507769B2 (en) * 2004-03-22 2009-03-24 Laboratoires Besins International Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen
EA011295B1 (ru) * 2004-10-14 2009-02-27 Лаборатуар Безен Энтернасьональ Рецептура геля с 4-гидрокситамоксифеном
EP1647271A1 (en) * 2004-10-14 2006-04-19 Laboratoires Besins International 4-Hydroxy tamoxifen gel formulations
GB0602739D0 (en) * 2006-02-10 2006-03-22 Ccbr As Breast tissue density measure
EP2104489A2 (en) * 2006-12-26 2009-09-30 FemmePharma Holding Company, Inc. Topical administration of danazol
WO2009065918A1 (en) * 2007-11-22 2009-05-28 Novo Nordisk Health Care Ag Stabilisation of liquid-formulated factor vii(a) polypeptides by aldehyde-containing compounds
US20110003000A1 (en) * 2009-07-06 2011-01-06 Femmepharma Holding Company, Inc. Transvaginal Delivery of Drugs
EP4220178A3 (en) * 2014-05-12 2023-08-16 Quest Diagnostics Investments Incorporated Quantitation of tamoxifen and metabolites thereof by mass spectrometry
WO2018034945A1 (en) 2016-08-19 2018-02-22 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Selective estrogen-receptor modulators (serms) confer protection against photoreceptor degeneration
TWI793165B (zh) 2017-09-11 2023-02-21 美商阿托薩醫療公司 製造及使用因多昔芬(endoxifen)之方法
MX2022000203A (es) 2019-07-03 2022-03-22 Atossa Therapeutics Inc Composiciones de liberacion sostenida de endoxifeno.
WO2023026139A1 (en) * 2021-08-23 2023-03-02 Singh Divya Dhananjay Pharmaceutical composition comprising 4- hydroxytamoxifen for the treatment of mastalgia

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2558373B1 (fr) 1984-01-20 1987-07-03 Mauvais Jarvis Pierre Medicament antioestrogene a base de 4-hydroxytamoxifene pour administration percutanee
ATE80152T1 (de) * 1987-04-21 1992-09-15 Heumann Pharma Gmbh & Co Stabile loesungsmitteladdukte von z-1-(p-betadimethylamino-ethoxyphenyl)-1-(p-hydroxyphenyl) 2-phenylbut-1-en.
US5045553A (en) * 1987-06-24 1991-09-03 Fujisawa Pharmaceutical Company, Ltd. Pharmaceutical composition for percutaneous drug absorption and percutaneous drug absorption promoter
US5002938A (en) * 1988-03-21 1991-03-26 Bristol-Myers Squibb Company Antifungal gel formulations
DE3836862A1 (de) 1988-10-27 1990-05-03 Schering Ag Mittel zur transdermalen applikation von steroidhormonen
TW218849B (https=) 1991-05-17 1994-01-11 Bristol Myers Squibb Co
JPH0679002A (ja) * 1993-12-14 1994-03-22 Hisamitsu Pharmaceut Co Inc 経皮投与用パッチシステム
US5613958A (en) 1993-05-12 1997-03-25 Pp Holdings Inc. Transdermal delivery systems for the modulated administration of drugs
DE4407742C1 (de) * 1994-03-08 1995-06-22 Hexal Pharma Gmbh Transdermales System in Form eines Pflasters mit einem Tamoxifen-Derivat
US5720963A (en) * 1994-08-26 1998-02-24 Mary Kay Inc. Barrier disruption treatments for structurally deteriorated skin
DE4434165A1 (de) * 1994-09-24 1996-03-28 Cassella Ag Haarfärbemittel
US6083996A (en) * 1997-11-05 2000-07-04 Nexmed Holdings, Inc. Topical compositions for NSAI drug delivery
US6013270A (en) * 1998-04-20 2000-01-11 The Procter & Gamble Company Skin care kit
DE10033853A1 (de) * 2000-07-12 2002-01-31 Hexal Ag Transdermales therapeutisches System mit hochdispersem Siliziumdioxid
US6503894B1 (en) * 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
DK1317921T3 (da) * 2001-12-07 2009-12-21 Besins Mfg Belgium Farmaceutisk sammensætning i form af en gel eller oplösning med dihydrotestosteron, fremgangsmåde til fremstilling og anvendelser heraf
MXPA05006526A (es) * 2002-12-18 2006-02-17 Besins Int Lab Tratamiento de mastalgia con 4-hidroxi tamoxifen.
ES2456958T3 (es) * 2003-04-01 2014-04-24 Besins Healthcare Luxembourg Sarl Formulaciones para prevención y tratamiento de cáncer de seno con 4-hidroxi tamoxifen
JP4682129B2 (ja) 2003-06-09 2011-05-11 アセンド セラピュティクス インコーポレイテッド 4−ヒドロキシタモキシフェンによる過剰瘢痕化の治療及び予防
US7968532B2 (en) * 2003-12-15 2011-06-28 Besins Healthcare Luxembourg Treatment of gynecomastia with 4-hydroxy tamoxifen
US7507769B2 (en) * 2004-03-22 2009-03-24 Laboratoires Besins International Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen
US20050208139A1 (en) * 2004-03-22 2005-09-22 Ascend Therapeutics, Inc. Chemically stable compositions of 4-hydroxy tamoxifen
EP1647271A1 (en) * 2004-10-14 2006-04-19 Laboratoires Besins International 4-Hydroxy tamoxifen gel formulations

Similar Documents

Publication Publication Date Title
JP2006514645A5 (https=)
Ghorpade Inoculation (tattoo) leprosy: a report of 31 cases
JP2006514967A5 (https=)
WO2004054558A3 (en) Reduction of breast density with 4-hydroxy tamoxifen
JP2007536277A5 (https=)
MX2007000420A (es) Suplemento de electrolito y metodo de uso.
CN204218038U (zh) 一种多功能保健鞋垫
JP2006514949A5 (https=)
CN211272183U (zh) 一种骨科脊柱用术后康复装置
CN203577160U (zh) 飞顿激光遮挡板
CN201631226U (zh) 一次性超声波探头套
CN203506952U (zh) 外科手指骨折固定器
CN201332709Y (zh) 磁疗围巾
CN220778856U (zh) 一种旋转式超声聚焦装置
CN201551395U (zh) 消化内科检查床
CN207101429U (zh) 一种用于人体各部位吸汗防过敏黑药膏贴
CN209966675U (zh) 一种便于使用的精神护理用嘴部支撑器
CN201879717U (zh) 放射科做胸部检查用铅板
CN202236048U (zh) 脑外科多功能枕
CN208541507U (zh) 冠心病pci术后上肢抬高垫
CN206508071U (zh) 一种兽医诊疗用动物撑口装置
CN201244148Y (zh) 俯卧位头面部支架
CN208625958U (zh) 一种骨科临床骨折用续骨装置
CN205432147U (zh) 一种中草药保健的硅胶垫片
YOSHIDA et al. A case of a cemento-ossifying fibroma associated with multiple impacted teeth arising in the right maxillary bone